Tag Archives: civic action

Drug Costs and Congress: Investments, Contributions and You

A scathing new article on Congress and its financial conflicts of interests with drug and device companies appears in STAT, a news firm specializing in health and science. It examines Senators and Representatives who have oversight of the FDA and … Continue reading

Posted in health insurance, medical bankruptcy, Medicare, pharmaceutical companies, policy and politics, prescription drugs, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment